OakChart

HeartBeam Inc

BEATHealthcare·Health Information Services·USA·Nano·NASD·Nov 11 • 9:54 AM ET

0.4099+0.0016 (0.39%)
2026-11-11 15:56 CET
Market cap
23.01 USD m
Revenue, TTM
0.00 USD m
Net income, TTM
-20.30 USD m
Free cash flow, TTM
-14.01 USD m
EPS diluted, TTM
-0.51
P/E
-
Compare

Price

BEAT against its 20, 50 and 200-day averages
2050200beatmissearnings
0.501.001.50202.1M404.2MMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26BEATclose 0.4120-day 0.4350-day 0.43200-day 0.800.41

89.8% under 4.00 on 17 Dec 2025. Last 15 sessions, 50.9% high to low

Profile

BEAT
52-week range, 2% of the way up
0.354.00

HeartBeam, Inc. is a development stage company, which engages in cardiovascular diagnostic technology. Its electrocardiogram (ECG) collection device provides physicians with cardiac diagnostic information for a patient that is outside of a medical institution. The device sends ECG signals to the patient's smartphone and on to a cloud-based software expert system. The company was founded by Branislav Vajdic in 2015 and is headquartered in Santa Clara, CA.

Employees16
IPONov 11, 2021
Beta-0.80
ATR, 14d0.05
Rel volume0.04
Short float4.91%
Insider own17.89%
Inst own15.13%

Snapshot

6 groups

Valuation

Index-
Market Cap23.10M
Enterprise Value14.38M
Income-20.30M
Sales0.00M
Book/sh0.15
Cash/sh0.15
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout-
Employees16
IPONov 11, 2021

Ratios

P/E-
Forward P/E-
PEG-
P/S-
P/B2.82
P/C2.65
P/FCF-
EV/EBITDA-
EV/Sales-
Quick Ratio3.61
Current Ratio3.66
Debt/Eq0.00
LT Debt/Eq0.00
Option/ShortNo / Yes

Earnings

EPS (ttm)-0.51
EPS next Y-0.29
EPS next Q-0.09
EPS this Y38.17%
EPS next Y25.22%
EPS next 5Y28.15%
EPS past 3/5Y26.76% -36.66%
Sales past 3/5Y- -
EPS Y/Y TTM26.80%
Sales Y/Y TTM-
EPS Q/Q35.03%
Sales Q/Q-
EarningsNov 12 AMC
EPS/Sales Surpr.-16.28% -100.00%

Ownership

Insider Own17.89%
Insider Trans0.00%
Inst Own15.13%
Inst Trans11.53%
ROA-244.27%
ROE-328.44%
ROIC-248.21%
Gross Margin-
Oper. Margin-
Profit Margin-
SMA20-4.72%
SMA50-4.98%
SMA200-49.04%
Trades-

Technical

Shs Outstand56.35M
Shs Float46.27M
Short Float4.91%
Short Ratio0.31
Short Interest2.27M
52W High4.00 -89.75%
52W Low0.35 15.46%
Volatility6.74% 10.20%
ATR (14)0.05
RSI (14)46.38
Beta-0.80
Rel Volume0.04
Avg Volume7.38M
Volume33,373

Performance

Perf Week-3.35%
Perf Month2.02%
Perf Quarter-30.50%
Perf Half Y-59.42%
Perf YTD-82.92%
Perf Year-76.17%
Perf 3Y-66.94%
Perf 5Y-91.26%
Perf 10Y-
Recom1.67
Target Price3.50
Prev Close0.41
Price0.41
Change %0.39%

Analyst ratings

latest 9 of 9
DateActionAnalystRating changeTargetImplied
Sep 22, 2026DowngradeHH.C. WainwrightBuy → Neutral
Jul 14, 2026InitiatedMMaxim GroupBuy$2+387.9%
Apr 20, 2026DowngradeDD. Boral CapitalBuy → Hold
Mar 31, 2026InitiatedRB. Riley SecuritiesBuy$4+875.8%
Mar 27, 2026InitiatedDD. Boral CapitalBuy$5+1,119.8%
Mar 16, 2026DowngradeTThe Benchmark CompanyBuy → Speculative Buy$8+1,851.7%
Dec 11, 2025UpgradeTThe Benchmark CompanySpeculative Buy → Buy$8+1,851.7%
Dec 08, 2025InitiatedHH.C. WainwrightBuy$2.50+509.9%
Oct 31, 2025InitiatedRRoth CapitalBuy$4+875.8%

Peers

Mkt cap
TickerCompanyMkt cap
HSCSHeartSciences Inc10.83M
DRIODarioHealth Corp26.36M
IRTCiRhythm Holdings Inc2.94B
TEMTempus AI Inc14.83B
TDOCTeladoc Health Inc1.62B
AMWLAmerican Well Corp208.45M
LFMDLifeMD Inc84.78M
OMDAOmada Health Inc962.21M
BFLYButterfly Network Inc1.84B
ECORElectroCore Inc71.50M

Insider trading

11 filings
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
Cruickshank TimCFOApr 16 '26Buy0.8031,25025,00072,230Apr 16 08:48 PM
Elfrink WillemDirectorApr 16 '26Buy0.80187,500150,000538,667Apr 16 08:48 PM
JAFF MICHAEL RDirectorApr 16 '26Buy0.8031,25025,00031,250Apr 16 08:47 PM
Vajdic BranislavDirectorApr 16 '26Buy0.8031,25025,000909,914Apr 16 08:47 PM
Ferrari RichardDirectorApr 16 '26Buy0.8062,50050,000291,636Apr 16 08:47 PM
ENO Robert PaulPresidentApr 16 '26Buy0.8012,50010,00036,742Apr 16 08:47 PM
Ortigas-Wedekind MargaDirectorApr 16 '26Buy0.8025,00020,000137,293Apr 16 08:46 PM
STROME MARK EDirectorApr 16 '26Buy0.80750,000600,0003,650,000Apr 16 08:46 PM
STROME MARK E10% OwnerDec 17 '25Sale3.58250,000895,0002,900,000Dec 22 05:44 PM
de Urioste GeorgeDirectorDec 18 '25Sale2.8333,18593,9140Dec 19 05:10 PM
de Urioste GeorgeDirectorDec 17 '25Sale3.6823,96188,17633,185Dec 19 05:10 PM

Held by

AUM
TickerCompanyAUM
VTIVanguard Morningstar Total Stock Market ETFAUM: 687.42B
VXFVanguard Extended Market Index ETFAUM: 30.47B
IWCiShares Micro-Cap ETFAUM: 1.22B

News

latest 14 of 206
  • HeartBeam's Promised Commercial Metrics Face Their Test As Cash Thins And Stock Sinks (Earnings Whispers) -6.93%
  • HeartBeam to Host Third Quarter 2026 Results Conference Call on Thursday, November 12, 2026 at 4:30 p.m. Eastern Time (Business Wire) +5.16%
  • HeartBeam Announces Positive Heart Attack Pilot Study Results at TCT 2026: Patient-Recorded 3D ECG Shown to Be as Accurate as Standard 12-Lead ECG (Business Wire) -25.64%
  • HeartBeam to Present Results of ALIGN-ACS Study for Heart Attack Assessment at TCT 2026 on November 1, 2026 (Business Wire) +32.82%
  • HeartBeam's Heart Attack Assessment Technology Accepted into FDA's Total Product Life Cycle Advisory Program (TAP) (Business Wire)
  • Loading…
  • HEADSTART-ACS Completes Enrollment Ahead of Schedule, the Largest Heart Attack Detection Study to Date Using HeartBeam Technology (Business Wire)
  • HeartBeam Joins European EXIT-CVD Research Consortium to Advance At-Home ECG Monitoring for Early Detection of Acute Coronary Syndrome (ACS) in High-Risk Patients (Business Wire) +9.82%
  • HeartBeam stock soars on FDA breakthrough designation (Investing.com) +50.53%
  • HeartBeam Receives FDA Breakthrough Device Designation for Heart Attack Assessment (Business Wire)
  • HeartBeam, Inc. Letter to Shareholders (Business Wire) +6.97%
  • HeartBeam Inc (BEAT) (Q2 2026) Earnings Call Highlights: FDA Submission Advances and Commercial ... (GuruFocus.com) -15.34%
  • HeartBeam Reports Second Quarter 2026 Results (Business Wire)
  • HeartBeam Inc (BEAT) Q2 2026 Earnings Report Preview: What To Look For (GuruFocus.com)

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q32026-11-12--0.090--0.083
2026Q22026-08-13-0.100-0.086-0.1000.000.155
2026Q12026-05-13-0.120-0.135-0.1160.000.154
2025Q42026-03-12-0.140-0.138-0.1460.000.004
2025Q32025-11-13-0.150-0.129-0.1530.000.883
2025Q22025-08-13-0.150-0.160-0.1470.000.002
2025Q12025-05-13-0.180-0.150-0.1810.000.002
2024Q42025-03-13-0.180-0.190-0.1830.000.001
2024Q32024-11-07-0.190-0.170-0.1860.000.001
2024Q22024-08-14-0.190-0.165-0.1870.000.002
2024Q12024-05-09-0.170-0.150-0.1740.000.001
2023Q42024-03-200.070-0.123-0.1470.000.003
2023Q32023-11-14-0.130-0.113-0.1310.000.003
2023Q22023-08-10-0.160-0.230-0.1600.000.002
2023Q12023-05-11-0.500-0.470-0.5030.000.002
2022Q42023-03-16-0.450-0.347-0.4630.000.003

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2021FY-1.030-0.390-0.567--
2022FY-1.590-1.393-1.5870.000.00
2023FY-0.720-0.620-0.7200.000.00
2024FY-0.730-0.730-0.7300.000.00
2025FY-0.620-0.613-0.6200.000.00
2026FY--0.383--0.29
2027FY--0.287--3.74
2028FY--0.230--13.25
2029FY-0.250--55.60
2030FY-0.600--100.9

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q3S2026-11-033100.080.020.20
2026Q3S2026-10-283010.080.000.20
2026Q3S2026-09-213030.080.000.20
2026Q3S2026-08-292020.110.030.20
2026Q3S2026-08-223020.110.030.20
2026Q3S2026-08-164020.130.030.20
2026Q3S2026-08-145020.190.030.43
2026Q3S2026-08-135000.240.080.43
2026Q3S2026-08-045000.240.080.43
2026Q3S2026-07-285010.240.080.43
2026Q3S2026-07-135120.240.080.43
2026Q3S2026-05-214120.280.100.43
2026Q3S2026-05-144110.510.201.00
2026Q3S2026-05-064020.550.171.00

Estimate history

EPS, annual-0.066-0.131-0.567-1.587-0.72-0.73-0.623-0.5103
Period2019202020212022202320242025TTM
EPS, quarterly-0.187-0.186-0.183-0.181-0.147-0.153-0.146-0.116-0.096
PeriodQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26
Sales, annual00000000
Period2019202020212022202320242025TTM
Sales, quarterly000000000
PeriodQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26
Shares, annual8.1678.1677.818.0126.32926.96140.11756.349
Period2019202020212022202320242025MRQ
Shares, quarterly26.56226.59526.96133.73534.0234.34140.11741.13256.349
PeriodQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY
Total Revenue0.000.000.000.000.000.000.000.00
Cost of Goods Sold Incl. D&A0.110.040.010.000.000.000.000.00
Gross Profit-0.11-0.04-0.010.000.000.000.000.00
Selling, General and Administrative Excl. Other20.3021.1019.8815.3113.032.290.790.29
Research and Development11.3313.4511.056.805.680.260.130.04
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income-20.41-21.14-19.89-15.31-13.03-2.29-0.79-0.29
Interest Expense0.000.000.000.000.002.170.280.24
Unusual Expense0.000.000.000.00-0.00-0.020.000.00
Net Income Before Taxes-20.30-21.02-19.45-14.64-12.96-4.43-1.07-0.54
Income Taxes0.000.000.000.000.000.000.000.00
Consolidated Net Income-20.30-21.02-19.45-14.64-12.96-4.43-1.07-0.54
Net Income From Continuing Operations-20.30-21.02-19.45-14.64-12.96-4.43-1.07-0.54
Net Income-20.30-21.02-19.45-14.64-12.96-4.43-1.07-0.54
EPS (Recurring)-0.38-0.62-0.73-0.72-1.59-0.57-0.13-0.07
EPS (Basic, Before Extraordinaries)-0.51-0.62-0.73-0.72-1.59-0.57-0.13-0.07
EPS (Diluted)-0.51-0.62-0.73-0.72-1.59-0.57-0.13-0.07
EBITDA-20.30-21.10-19.88-15.31-13.03-2.29-0.79-0.29
Non-Operating Income (Expense)0.110.120.440.680.070.000.000.00
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense5.785.154.303.211.120.190.010.00
Shares Outstanding56.3540.1226.9626.338.017.818.178.17
Market Capitalization23.0123.0161.3361.8639.0423.8924.43-

Income statement, quarterly

Currency USD, millions
Metric2026Q22026Q12025Q42025Q32025Q22025Q12024Q42024Q3
Total Revenue0.000.000.000.000.000.000.000.00
Cost of Goods Sold Incl. D&A0.060.020.020.010.010.010.010.00
Gross Profit-0.06-0.02-0.02-0.01-0.01-0.01-0.010.00
Selling, General and Administrative Excl. Other5.044.695.295.285.035.504.945.07
Research and Development2.332.373.353.283.333.492.892.89
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income-5.09-4.72-5.31-5.29-5.04-5.50-4.94-5.07
Interest Expense0.000.000.000.000.000.000.000.00
Unusual Expense0.000.000.000.000.000.000.000.00
Net Income Before Taxes-5.04-4.70-5.30-5.25-4.97-5.48-4.91-4.98
Income Taxes0.000.000.000.000.000.000.000.00
Consolidated Net Income-5.04-4.70-5.30-5.25-4.97-5.48-4.91-4.98
Net Income From Continuing Operations-5.04-4.70-5.30-5.25-4.97-5.48-4.91-4.98
Net Income-5.04-4.70-5.30-5.25-4.97-5.48-4.91-4.98
EPS (Recurring)-0.10-0.12-0.15-0.15-0.15-0.18-0.18-0.19
EPS (Basic, Before Extraordinaries)-0.10-0.12-0.15-0.15-0.15-0.18-0.18-0.19
EPS (Diluted)-0.10-0.12-0.15-0.15-0.15-0.18-0.18-0.19
EBITDA-5.04-4.69-5.29-5.28-5.03-5.50-4.94-5.07
Non-Operating Income (Expense)0.050.020.010.040.060.020.040.09
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense1.701.221.431.431.181.111.001.05
Shares Outstanding56.3541.1340.1234.3434.0233.7326.9626.59
Market Capitalization23.0150.1382.6656.6142.2667.7961.3361.62

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY
Cash & Short Term Investments4.382.3816.193.5913.190.020.01
Short Term Receivables0.000.000.000.000.000.000.00
Inventories0.100.000.000.000.000.000.00
Other Current Assets0.200.390.640.450.810.030.00
Total Current Assets4.682.7716.824.0414.000.050.01
Net Property, Plant & Equipment1.100.450.260.000.000.000.00
Total Investments and Advances0.000.000.000.000.000.000.00
Intangible Assets---0.000.000.000.00
Other Assets0.060.060.050.000.000.000.00
Total Assets5.843.2817.134.0414.000.050.01
Short Term Debt Incl. Current Port. of LT Debt0.000.000.000.000.004.290.04
Accounts Payable0.000.000.000.000.000.000.00
Other Current Liabilities3.241.621.191.670.590.540.31
Total Current Liabilities3.241.621.191.670.594.840.35
Long Term Debt0.000.000.000.000.000.003.38
Provision for Risks Charges0.000.000.000.000.000.000.00
Other Liabilities0.000.000.000.000.000.000.00
Total Liabilities3.241.621.191.670.594.843.73
Non-Equity Reserves0.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.00
Common Equity2.601.6515.942.3713.41-4.79-3.73
Total Shareholders Equity2.601.6515.942.3713.41-4.79-3.73
Accumulated Minority Interest0.000.000.000.000.000.000.00
Total Equity2.601.6515.942.3713.41-4.79-3.73
Total Liabilities & Stockholders Equity5.843.2817.134.0414.000.050.01
Book Value Per Share0.060.060.610.301.72-0.59-0.46
Tangible Book Value Per Share0.060.060.610.301.72-0.59-0.46
Full-Time Employees162115155--
Price to Book Ratio2.8112.743.326.801.79-4.74-
Return on Assets-460.91-190.60-138.30-143.73-63.04-3,682.76-
Return on Equity-987.32-221.11-159.89-164.24-102.68--
Return on Invested Capital-807.34-1,175.82-91.86-546.00-33.02--
Quick Ratio1.411.7114.092.4323.810.010.02
Current Ratio1.451.7114.092.4323.810.010.02

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY
Net Income-20.30-21.02-19.45-14.64-12.96-4.43-1.07-0.54
Depreciation0.110.040.01-----
Other Funds (Non Cash)6.615.374.303.211.122.330.290.24
Funds from Operations-13.58-15.60-15.14-11.43-11.84-2.09-0.78-0.29
Extraordinary Item0.000.000.000.000.000.000.000.00
Changes in Working Capital0.561.610.67-0.661.89-1.140.180.08
Cash from Operating Activities-13.02-13.99-14.47-12.09-9.95-3.23-0.60-0.22
Capital Expenditures-0.99-0.60-0.20-0.260.000.000.000.00
Net Assets From Acquisitions0.000.000.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.000.000.00
Purchase or Sale of Investments1.800.000.000.000.000.000.000.00
Purchase of Investments0.00-3.760.000.000.000.000.000.00
Sale Or Maturity of Investments1.803.760.000.000.000.000.000.00
Other Uses0.000.000.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.000.000.00
Cash from Investing Activities0.80-0.60-0.20-0.260.000.000.000.00
Cash Dividends Paid0.000.000.000.000.000.000.000.00
Change in Capital Stock17.6816.590.8724.990.3514.710.000.00
Repurchase of Common Pref Stock0.000.000.000.000.000.000.000.00
Sale of Common Pref Stock17.6816.590.8724.990.3514.710.000.00
Proceedsfrom Stock Options17.6616.580.7324.780.3514.710.000.00
Issuance or Reduction of Debt, Net0.000.000.000.000.001.690.620.21
Change in Long Term Debt0.000.000.000.000.001.720.640.07
Issuance of Long Term Debt0.000.000.000.000.001.720.640.07
Reduction of Long Term Debt0.000.000.000.000.000.000.000.00
Net Financing Active Other Cash Flow0.000.000.000.000.000.000.000.00
Other Financing Activities Uses0.000.000.000.000.000.000.000.00
Cash from Financing Activities17.6816.590.8724.990.3516.400.620.21
Net Change in Cash5.472.00-13.8112.64-9.6013.170.02-0.01
Free Cash Flow-14.01-14.59-14.67-12.35-9.95-3.23-0.60-0.22
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.000.00
Deferred Taxes & Investment Tax Credit-0.000.000.000.000.000.000.00

Balance sheet, quarterly

Currency USD, millions
Metric2026Q22026Q12025Q42025Q32025Q22025Q1
Cash & Short Term Investments8.722.044.381.865.058.15
Short Term Receivables0.000.000.000.000.000.00
Inventories0.110.130.100.000.000.00
Other Current Assets0.160.260.200.270.310.46
Total Current Assets9.002.444.682.135.368.61
Net Property, Plant & Equipment1.581.441.100.690.560.44
Total Investments and Advances0.060.060.000.060.060.06
Intangible Assets0.000.00-0.000.000.00
Other Assets0.000.000.060.000.000.00
Total Assets10.643.935.842.885.989.11
Short Term Debt Incl. Current Port. of LT Debt0.000.000.000.000.000.00
Accounts Payable0.000.000.000.000.000.00
Other Current Liabilities2.463.293.242.471.801.58
Total Current Liabilities2.463.293.242.471.801.58
Long Term Debt0.000.000.000.000.000.00
Provision for Risks Charges0.000.000.000.000.000.00
Other Liabilities0.000.000.000.000.000.00
Total Liabilities2.463.293.242.471.801.58
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity8.180.642.600.414.187.53
Total Shareholders Equity8.180.642.600.414.187.53
Accumulated Minority Interest0.000.000.000.000.000.00
Total Equity8.180.642.600.414.187.53
Total Liabilities & Stockholders Equity10.643.935.842.885.989.11
Book Value Per Share0.150.020.060.010.120.22
Tangible Book Value Per Share0.150.020.060.010.120.22
Full-Time Employees--16-19-
Price to Book Ratio2.8118.80203.0513.425.6032.76
Return on Assets-244.27-310.39-460.91-432.60-252.61-178.75
Return on Equity-328.44-495.61-987.32-792.01-315.70-202.58
Return on Invested Capital-61.62-740.16-203.69-1,294.33-118.94-72.84
Quick Ratio3.610.701.410.862.985.46
Current Ratio3.660.741.450.862.985.46

Cash flow, quarterly

Currency USD, millions
Metric2026Q22026Q12025Q42025Q32025Q22025Q1
Net Income-5.04-4.70-5.30-5.25-4.97-5.48
Depreciation0.060.020.020.010.010.01
Other Funds (Non Cash)2.311.221.651.431.181.11
Funds from Operations-2.68-3.46-3.63-3.81-3.79-4.37
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital-0.67-0.150.730.650.34-0.11
Cash from Operating Activities-3.34-3.61-2.91-3.16-3.44-4.48
Capital Expenditures-0.25-0.25-0.42-0.08-0.100.00
Net Assets From Acquisitions0.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.00
Purchase or Sale of Investments0.000.000.001.801.96-3.76
Purchase of Investments0.000.000.000.000.00-3.76
Sale Or Maturity of Investments0.000.000.001.801.960.00
Other Uses0.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.00
Cash from Investing Activities-0.25-0.25-0.421.721.86-3.76
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock10.281.515.850.040.4510.25
Repurchase of Common Pref Stock0.000.000.000.000.000.00
Sale of Common Pref Stock10.281.515.850.040.4510.25
Proceedsfrom Stock Options10.271.515.830.040.4510.25
Issuance or Reduction of Debt, Net0.000.000.000.000.000.00
Change in Long Term Debt0.000.000.000.000.000.00
Issuance of Long Term Debt0.000.000.000.000.000.00
Reduction of Long Term Debt0.000.000.000.000.000.00
Net Financing Active Other Cash Flow0.000.000.000.000.000.00
Other Financing Activities Uses0.000.000.000.000.000.00
Cash from Financing Activities10.281.515.850.040.4510.25
Net Change in Cash6.68-2.342.52-1.40-1.132.01
Free Cash Flow-3.59-3.86-3.32-3.24-3.55-4.48

Revenue breakdown

Revenue split-

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-304.91%2.3M46.3M7.30M
2026-10-155.37%2.5M46.3M7.13M
2026-09-305.44%2.5M45.8M629.10K
2026-09-154.64%2.1M45.8M667.93K
2026-08-314.25%1.9M45.7M714.12K
2026-08-145.31%2.4M45.7M751.15K
2026-07-314.08%1.8M45.0M798.06K
2026-07-155.23%2.5M48.6M1.03M
2026-06-303.68%1.8M48.6M944.64K
2026-06-154.50%2.1M47.4M920.27K
2026-05-294.87%2.3M47.1M1.51M
2026-05-155.50%2.6M47.1M1.51M
2026-04-306.39%2.9M45.6M1.45M
2026-04-156.54%3.1M47.2M1.32M
2026-03-319.54%3.1M33.0M1.36M
2026-03-1312.36%4.1M33.0M3.69M
2026-02-275.96%1.9M32.2M12.78M
2026-02-135.98%1.9M32.2M13.06M
2026-01-308.83%2.4M27.7M13.01M
2026-01-1511.12%3.1M27.7M12.67M

Option chain

expiry 2026-11-11
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
No option chain for this symbol.

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-10-094Statement of changes in beneficial ownership of securities2026-10-02SEC
2026-10-094Statement of changes in beneficial ownership of securities2026-10-02SEC
2026-10-094Statement of changes in beneficial ownership of securities2026-10-02SEC
2026-10-094Statement of changes in beneficial ownership of securities2026-10-02SEC
2026-10-094Statement of changes in beneficial ownership of securities2026-10-02SEC
2026-10-094Statement of changes in beneficial ownership of securities2026-10-02SEC
2026-08-148-KCurrent report2026-08-14SEC
2026-08-14424B5SEC
2026-08-13SCHEDULE 13D/ASEC
2026-08-1310-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-08-068-K/A2026-06-18SEC
2026-08-038-KCurrent report2026-07-31SEC
2026-07-244Statement of changes in beneficial ownership of securities2026-07-24SEC
2026-07-244Statement of changes in beneficial ownership of securities2026-07-24SEC
2026-07-244Statement of changes in beneficial ownership of securities2026-06-15SEC
2026-07-028-KCurrent report2026-06-30SEC
2026-06-25DEFA14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934SEC
2026-06-248-KCurrent report2026-06-18SEC
2026-06-228-KCurrent report2026-06-15SEC
2026-06-18DEF 14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 19342026-06-18SEC
2026-06-05PRE 14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 19342026-06-05SEC
2026-05-1310-QQuarterly report pursuant to Section 13 or 15(d)2026-03-31SEC
2026-04-244/A2026-04-16SEC
2026-04-164Statement of changes in beneficial ownership of securities2026-04-16SEC
2026-04-164Statement of changes in beneficial ownership of securities2026-04-16SEC
2026-04-164Statement of changes in beneficial ownership of securities2026-04-16SEC
2026-04-164Statement of changes in beneficial ownership of securities2026-04-16SEC
2026-04-164Statement of changes in beneficial ownership of securities2026-04-16SEC
2026-04-164Statement of changes in beneficial ownership of securities2026-04-16SEC
2026-04-164Statement of changes in beneficial ownership of securities2026-04-16SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-090000
2026-080000
2026-070000
2026-060000
2026-050000
2026-04905.00K800
2026-030000
2026-020000
2026-010000
2025-12001.08M3
2025-110000

Institutional holders

Manager% owned
VANGUARD CAPITAL MANAGEMENT LLC3.85%
BlackRock, Inc.1.78%
CORSAIR CAPITAL MANAGEMENT, L.P.1.64%
Bleichroeder LP1.13%
GEODE CAPITAL MANAGEMENT, LLC0.85%
Sigma Planning Corp0.69%
Smith Salley Wealth Management0.65%
RITHOLTZ WEALTH MANAGEMENT0.50%
VANGUARD FIDUCIARY TRUST CO0.50%
Beacon Pointe Advisors, LLC0.45%

Funds

Fund% owned
VANGUARD TOTAL STOCK MARKET INDEX FUND2.61%
VANGUARD EXTENDED MARKET INDEX FUND1.18%
Fidelity Extended Market Index Fund0.44%
iShares Micro-Cap ETF0.28%
Fidelity Series Total Market Index Fund0.13%
Fidelity Total Market Index Fund0.12%
VANGUARD BALANCED INDEX FUND0.06%
1290 VT Micro Cap Portfolio0.02%
Fidelity Nasdaq Composite Index Fund0.00%
Blackstone Alternative Multi-Strategy Fund-0.01%

OakChart. BEAT. Cached 15 minutes.